Antibiotic Tequin risky to diabetes patients: "Tequin (gatifloxacin), one of a group of broad-spectrum antibiotics used to treat lung, sinus and urinary tract infections and sexually transmitted diseases, may raise or reduce blood sugar to a dangerous level in diabetics, found a new study scheduled to appear in the March 30 issue of the New England Journal of Medicine.
Previous studies have already found that gatifloxacin is associated with both hypoglycemia and hyperglycemia." [Foodconsumer.org]
